AARTIPHARM

Aarti Pharmalabs Share Price

 

 

Invest in Aarti Pharmalabs with 2.8X leverage

Invest with MTF

Performance

  • Low
  • ₹711
  • High
  • ₹721
  • 52 Week Low
  • ₹557
  • 52 Week High
  • ₹971
  • Open Price₹713
  • Previous Close₹713
  • Volume57,234

Investment Returns

  • Over 1 Month -16.01%
  • Over 3 Month -5.06%
  • Over 6 Month -9.7%
  • Over 1 Year + 9.41%

Smart Investing Starts Here Start SIP with Aarti Pharmalabs for Steady Growth!

Invest Now

Aarti Pharmalabs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 27.2
  • PEG Ratio
  • 5.3
  • Market Cap Cr
  • 6,519
  • P/B Ratio
  • 3.5
  • Average True Range
  • 29.47
  • EPS
  • 26.45
  • Dividend Yield
  • 0.7
  • MACD Signal
  • -13.13
  • RSI
  • 26.26
  • MFI
  • 14.66

Aarti Pharmalabs Financials

Aarti Pharmalabs Technicals

EMA & SMA

Current Price
₹719.20
+ 6 (0.84%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹807.21
  • 50 Day
  • ₹833.76
  • 100 Day
  • ₹839.45
  • 200 Day
  • ₹805.66

Resistance and Support

723.05 Pivot Speed
  • R3 775.05
  • R2 761.00
  • R1 737.10
  • S1 699.15
  • S2 685.10
  • S3 661.20

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Aarti Pharmalabs Ltd. is a leading pharmaceutical company in India, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. It caters to global markets, providing high-quality and innovative solutions for various therapeutic segments.

Aarti Pharmalabs has an operating revenue of Rs. 1,906.08 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 17% is great, ROE of 13% is good. The company has a reasonable debt to equity of 5%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 23% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 57 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 143 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Aarti Pharmalabs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-09 Quarterly Results
2025-08-12 Quarterly Results
2025-05-10 Audited Results & Final Dividend
2025-02-05 Quarterly Results, Dividend & Others To consider other business matters. per share(40%)Interim Dividend
2024-10-28 Quarterly Results
Date Purpose Remarks
2025-09-15 FINAL Rs.2.50 per share(50%)Final Dividend
2025-02-14 INTERIM Rs.2.50 per share(50%)Interim Dividend
2024-07-31 FINAL Rs.1.00 per share(20%)Final Dividend
2024-02-19 INTERIM Rs.2.00 per share(40%)Interim Dividend
View Aarti Pharmalabs Dividend History Arrow

Aarti Pharmalabs F&O

Aarti Pharmalabs Shareholding Pattern

42.88%
0.79%
5.3%
8.02%
0%
35.39%
7.62%

About Aarti Pharmalabs

  • NSE Symbol
  • AARTIPHARM
  • BSE Symbol
  • 543748
  • Managing Director
  • Mr. Narendra J Salvi
  • ISIN
  • INE0LRU01027

Similar Stocks to Aarti Pharmalabs

Aarti Pharmalabs FAQs

Aarti Pharmalabs share price is ₹719 As on 17 November, 2025 | 09:51

The Market Cap of Aarti Pharmalabs is ₹6519.4 Cr As on 17 November, 2025 | 09:51

The P/E ratio of Aarti Pharmalabs is 27.2 As on 17 November, 2025 | 09:51

The PB ratio of Aarti Pharmalabs is 3.5 As on 17 November, 2025 | 09:51

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23